# DESCRIPTION

## FIELD OF THE INVENTION

- relate to molecular biology

## BACKGROUND OF THE INVENTION

- introduce PCR
- describe blood-based PCR diagnoses
- limitations of blood-based PCR diagnoses

## SUMMARY OF INVENTION

- introduce mutant thermostable Type-A DNA polymerase
- describe mutations of mutant polymerase
- describe properties of mutant polymerase
- describe composition and kit
- describe method of using mutant polymerase

## DETAILED DESCRIPTION OF THE INVENTION

- introduce mutant DNA polymerases

### 1. Mutant DNA Polymerases

- define mutant DNA polymerases
- describe resistance to inhibitors
- specify mutations at residues 507, 59, 155, 245, and 749
- provide examples of inhibitors
- describe increased polymerization rate
- define genetically engineered and mutant
- describe site-directed mutants
- discuss replacement of sequences
- define isolated polypeptide
- describe percent identity of sequences
- discuss conservative amino acid substitutions
- provide examples of mutations
- describe production of recombinant proteins
- discuss functional equivalents
- describe obtaining recombinant polypeptides
- discuss chemical synthesis
- describe production of mutant DNA polymerases
- provide compositions of mutant DNA polymerases

### 2. Nucleic Acids, Vectors, and Host Cells

- introduce nucleic acids that encode mutant DNA polymerases
- describe isolated nucleic acids
- provide recombinant constructs or vectors
- discuss regulatory sequences and expression vectors
- describe host cells and expression of polypeptides

### 3. Methods and Uses

- introduce mutant DNA polymerases
- describe primer extension method
- outline polymerization reaction conditions
- discuss various uses of mutant DNA polymerases
- describe use in PCR reactions
- discuss use in detecting blood infections and genetic mutations
- outline use in analyzing rare cells

### 4. Kits

- introduce kits for nucleic acid copying and amplification
- describe kit components
- outline mutant DNA polymerase containers
- discuss kit formats
- describe additional kit components
- outline control reaction components
- discuss kit instructions
- describe kit packaging materials
- outline kit uses
- define resistant to an inhibitor
- define target nucleic acid
- describe amplification process
- outline primer and extension nucleotides
- discuss hybridization conditions
- define stringent hybridization conditions
- outline ranges of values

## Example 1

### Generation and Screening of Mutant Polymerases

- generate and screen mutant Taq DNA polymerases

## Example 2

### Characterization of Mutant Enzymes' Resistance to EDTA

- examine mutant enzymes' ability to amplify target DNA in presence of EDTA
- compare mutant enzymes' resistance to EDTA

## Example 3

### Characterization of Mutant Enzymes' Resistance to Heparin

- examine mutant enzymes' ability to amplify target DNA in presence of heparin
- compare mutant enzymes' resistance to heparin

## Example 4

### Comparison of Taq 1C2 with Commercially Available DNA Polymerases

- compare Taq 1C2 with commercially available DNA polymerases
- rank DNA polymerases' resistance to EDTA and heparin

